Physics of Polymorphic Transitions in CeRuSn

We report a detailed study of the polymorphic transitions in ternary stannide CeRuSn on high quality single crystals through a combination of X-ray diffraction experiments conducted at 300, 275 and 120 K, and measurements of the thermal expansion, magnetization, and resistivity, along main crystallographic axes. In addition, the transition was followed as a function of pressure up to 0.8 GPa. The present X-ray diffraction data show that the room temperature polymorph consists of the lattice doubled along the c axis with respect to the CeCoAl-type structure consistent with previous reports. Upon cooling, the compound undergoes two successive transitions, first to a quintuple (290 K) and than to a triple CeCoAl superstructure at 225 K. The transitions are accompanied by a tremendous volume change due to a strong shrinking of the lattice along the c axis, which is clearly observed in thermal expansion. We advance arguments that the volume collapse originates from an increasing number of crystallographically inequivalent Ce sites and the change of ratio between the short and long Ce-Ru bonds. The observed properties of the polymorphic transition in CeRuSn are reminiscent of the transition in elementary Cerium, suggesting that similar physics, i.e., a Kondo influenced transition and strong lattice vibrations might be the driving forces

Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo

Adenoviruses are common pathogens, mostly targeting ocular, gastrointestinal and respiratory cells, but in some cases infection disseminates, presenting in severe clinical outcomes. Upon dissemination and contact with blood, coagulation factor X (FX) interacts directly with the adenovirus type 5 (Ad5) hexon. FX can act as a bridge to bind heparan sulphate proteoglycans, leading to substantial Ad5 hepatocyte uptake. FX “coating” also protects the virus from host IgM and complement-mediated neutralisation. However, the contribution of FX in determining Ad liver transduction whilst simultaneously shielding the virus from immune attack remains unclear. In this study, we demonstrate that the FX protection mechanism is not conserved amongst Ad types, and identify the hexon hypervariable regions (HVR) of Ad5 as the capsid proteins targeted by this host defense pathway. Using genetic and pharmacological approaches, we manipulate Ad5 HVR interactions to interrogate the interplay between viral cell transduction and immune neutralisation. We show that FX and inhibitory serum components can co-compete and virus neutralisation is influenced by both the location and extent of modifications to the Ad5 HVRs. We engineered Ad5-derived HVRs into the rare, native non FX-binding Ad26 to create Ad26.HVR5C. This enabled the virus to interact with FX at high affinity, as quantified by surface plasmon resonance, FX-mediated cell binding and transduction assays. Concomitantly, Ad26.HVR5C was also sensitised to immune attack in the absence of FX, a direct consequence of the engineered HVRs from Ad5. In both immune competent and deficient animals, Ad26.HVR5C hepatic gene transfer was mediated by FX following intravenous delivery. This study gives mechanistic insight into the pivotal role of the Ad5 HVRs in conferring sensitivity to virus neutralisation by IgM and classical complement-mediated attack. Furthermore, through this gain-of-function approach we demonstrate the dual functionality of FX in protecting Ad26.HVR5C against innate immune factors whilst determining liver targeting

Dissymmetrical tunnelling in heavy fermion metals

A tunnelling conductivity between a heavy fermion metal and a simple metallic point is considered. We show that at low temperatures this conductivity can be noticeably dissymmetrical with respect to the change of voltage bias. The dissymmetry can be observed in experiments on the heavy fermion metals whose electronic system has undergone the fermion condensation quantum phase transition.Comment: 7 pages, Revte

Proposed criteria for the evaluation of the scientific quality of mandatory rat and mouse feeding trials with whole food/feed derived from genetically modified plants

In recent years, animal feeding trials conducted with whole food/feed have been a focal issue in the controversy on the safety assessment of genetically modified (GM) plants and derived food/feed. Within the scientific community and among stakeholders, quite different views have been expressed on how these studies should be conducted, analysed and interpreted, what they might add in terms of information relevant to safety and whether 90-day rodent feeding trials should be mandatory. Despite the fact that the Commission Implementing Regulation (EU) No. 503/2013 (specifying the requirements for the risk assessment of GM food/feed) requests mandatory 90-day feeding trials for GM plants with single transformation events, the controversy continues. This is due to the fact that in 2016 the European Commission will have to review this particular provision in the legislation (ibid, Article 12), and because of questions raised by long-term feeding studies with GM maize